{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-032278","form_type":"8-K","ticker":"PALI","cik":"0001357459","company_name":"PALISADE BIO, INC.","filed_at":"2023-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.692625+00:00","generated_at":"2026-06-10T21:38:02.519008+00:00","sec_items":["1.01","5.02","3.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Palisade Bio appoints Mitchell Jones as CMO; grants inducement options and RSUs","bullets":["Mitchell Jones, M.D., Ph.D., appointed Chief Medical Officer effective Sept 5, 2023.","Herbert Slade ceased as CMO same date, will continue as consultant.","Inducement grant: 75,000 options at $0.6897/share, 54,700 RSUs; vest over 3 years.","Jones previously VP at Chemomab (CMMB), Finch Therapeutics (FNCH), Biora (BIOR); IBD expertise.","Employment: base salary $415,000, target bonus 40%, severance provisions."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-032278","json":"https://secwatch.observer/filing/0001493152-23-032278.json","markdown":"https://secwatch.observer/filing/0001493152-23-032278.md","text":"https://secwatch.observer/filing/0001493152-23-032278.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223032278/0001493152-23-032278-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223032278/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T21:38:02.519008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bb95c23ff8","claim":"Mitchell Jones was appointed as Chief Medical Officer at PALISADE BIO, INC..","evidence_excerpt":"Mitchell Jones, M.D., Ph.D. (“Dr. Jones”) has been appointed Chief Medical Officer effective September 5, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223032278/0001493152-23-032278-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}